CINCINNATI, OH — (Marketwired) — 02/03/14 — Triplefin, a member of the H. D. Smith family of companies, has been recognized as a Platinum-Level-Fit-Friendly Worksite by the American Heart Association for helping employees eat better and move more. This designation is an improvement from its Gold-Level designation of 2013.
“Physical activity and employee wellness are important priorities at Triplefin. We are honored and excited to be recognized by the American Heart Association as a Platinum-Level-Fit-Friendly Worksite,” said Joe Conda, president, H. D. Smith Specialty Solutions. “We’re committed to providing the best workplace environment possible. This will benefit our associates’ health and will have a positive impact on our daily activities at our worksite.
Triplefin currently offers its associates:
The Fit-Friendly Worksites program is a catalyst for positive change in the American workforce by helping worksites make their employees’ health and wellness a priority.
American employers are losing an estimated $225.8 billion a year because of healthcare expenses and health-related losses in productivity, and those numbers are rising. Many American adults spend most of their waking hours at sedentary jobs. Their lack of regular physical activity raises their risk for a host of medical problems, such as obesity, high blood pressure and diabetes. Employers face $12.7 billion in annual medical expenses due to obesity alone. The American Heart Association is working to change corporate cultures by motivating employees to start walking, which has the lowest dropout rate of any physical activity.
By example, Triplefin is committed to its associates’ health and well-being by being proactive with education, and communication and by developing a wellness culture. Associates are excited to be a part of company that makes this a priority every day.
Triplefin, headquartered in Cincinnati, Ohio, is operating as a wholly owned subsidiary of H. D. Smith. For 32 years, Triplefin has continually helped pharmaceutical brand managers remove barriers to brand access and adherence.
Today, more than 45 pharmaceutical manufacturing companies (including 15 of the top 20), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced success with its innovative solutions. Please visit www.triplefin.com.